Centrum 7/6  banner

Controlled Substances Act

Opioid epidemic’s impact on pharmacy sector

Opioid epidemic’s impact on pharmacy sector

The United States is battling what the Centers for Disease Control and Prevention (CDC) has labeled an epidemic of prescription drug abuse. According to CDC data, drug overdose deaths more than doubled between 2002 and 2015 (the latest year for which information is available). In 2015, drug overdose deaths exceeded 50,000 — which is more

Costco settles with DOJ over improper pharmacy controls

Costco settles with DOJ over improper pharmacy controls

WASHINGTON — Costco Wholesale Corp. has agreed to pay $11.75 million in a settlement with the Department of Justice (DOJ) on claims that it improperly filled prescriptions for controlled substances. Also under the settlement, over the next three years the Drug Enforcement Administration (DEA) can conduct unannounced and unrestricted inspections of all DEA-registered Costco pharmacy

McKesson to pay $150 million in DEA, DOJ settlement

McKesson to pay $150 million in DEA, DOJ settlement

SAN FRANCISCO — McKesson Corp. has agreed to pay $150 million in a settlement with the Drug Enforcement Administration (DEA) and Department of Justice (DOJ) involving its monitoring and reporting of suspicious controlled substance orders. McKesson said late Tuesday that under the administrative and civil settlements the DEA will suspend the company’s DEA registrations to

In Rx, ounce of prevention worth pound of cure

In Rx, ounce of prevention worth pound of cure

A regulatory inspection by the Drug Enforcement Administration or a state board of pharmacy can be a high stakes event. Penalties for violations of the federal Controlled Substances Act may include criminal penalties, significant civil monetary fines and administrative action up to and including a “show cause” proceeding to suspend or revoke a pharmacy’s controlled

PP_1170x120_10-25-21